7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 
      
    		                  
      operating activities:
    		                  
      net income
    		48,400,000 7,962,000 -13,260,000 12,323,000 16,998,000 8,754,000 6,323,000 38,681,000 -13,660,000 23,513,000 2,842,000 86,149,000 61,059,000 30,641,000 35,997,000 27,444,000 42,615,000 11,065,000 
      adjustments to reconcile net income to net cash from operating activities:
    		                  
      depreciation
    		22,711,000 23,093,000 22,130,000 20,672,000 23,207,000 20,075,000 20,306,000 20,664,000 17,993,000 18,989,000 18,931,000 47,496,000 31,611,000 15,867,000 16,703,000 16,395,000 15,683,000 15,379,000 
      amortization of intangible assets
    		5,649,000 11,923,000 18,674,000 19,640,000 19,858,000 19,755,000 20,124,000 20,058,000 20,182,000 20,501,000 20,607,000 61,596,000 41,378,000 20,182,000 21,443,000 21,239,000 21,778,000 22,282,000 
      loss on refinancing of debt
    		1,087,000   8,000 70,000              
      deferred income taxes
    		8,186,000 -9,024,000 -16,075,000 7,542,000 9,990,000 -4,658,000 -3,441,000 165,000 2,969,000 2,085,000 -1,770,000 17,153,000 10,416,000 5,633,000 -11,847,000 4,627,000 7,141,000 -3,637,000 
      share-based compensation expense
    		7,949,000 8,119,000 7,242,000 8,144,000 9,789,000 10,181,000 8,663,000 8,204,000 8,373,000 8,373,000 7,288,000 14,955,000 10,339,000 4,538,000  3,547,000 3,493,000 3,449,000 
      accretion of asset retirement obligations
    		601,000 562,000 574,000 723,000 637,000 636,000 642,000 730,000 556,000 555,000 572,000 1,645,000 1,118,000 520,000 501,000 598,000 602,000 551,000 
      unrealized foreign exchange gain
    		-10,508,000 13,527,000 5,359,000                
      unrealized (gain) loss on derivatives not designated as hedging instruments
    		1,389,000                  
      amortization of debt issuance costs
    		1,305,000 1,375,000 1,270,000 1,280,000 1,254,000 2,169,000 2,535,000 2,529,000 2,410,000 2,202,000 1,910,000 4,259,000 2,836,000 1,414,000 1,372,000 1,544,000 1,582,000 1,663,000 
      other
    		-1,275,000 -1,006,000 -1,468,000 -1,092,000 -1,017,000 -2,260,000 -998,000 -1,827,000 -869,000 -1,295,000 -1,328,000 -6,109,000 -4,043,000 -1,989,000 -6,554,000 -1,933,000 -1,398,000 -2,843,000 
      changes in operating assets and liabilities:
    		                  
      accounts receivable
    		-6,428,000 -4,546,000 13,630,000 -14,026,000 -6,019,000 -18,308,000 40,569,000 -22,026,000 -2,247,000 -7,674,000 10,223,000 -8,558,000 -13,921,000 -6,387,000 -10,608,000 20,853,000 -21,620,000 -4,134,000 
      inventories
    		9,040,000 4,176,000 -11,839,000 1,470,000 4,861,000 -7,032,000 -4,052,000 -9,106,000 3,011,000 5,635,000 -9,512,000 13,896,000 14,012,000 9,323,000 -16,816,000 -2,659,000 -1,869,000 1,099,000 
      other current assets
    		-4,698,000 -10,557,000 -3,693,000 6,891,000 309,000 -3,352,000 -250,000 4,895,000 8,328,000 -2,902,000 -6,318,000 -13,066,000 -6,683,000 -8,934,000 -5,777,000 1,242,000 3,307,000 -2,324,000 
      accounts payable
    		-8,375,000 -6,098,000 11,671,000 -7,528,000 2,843,000 5,321,000 -7,280,000 12,079,000 2,913,000 -10,715,000 -9,610,000 -13,367,000 -9,993,000 -12,742,000 20,052,000 -15,371,000 8,455,000 6,625,000 
      accrued liabilities
    		27,793,000 -4,345,000 -10,169,000 10,132,000 15,567,000 12,421,000 -31,006,000 14,889,000 -33,662,000 13,447,000 8,826,000 -1,874,000 -11,869,000 2,479,000 9,581,000 -3,610,000 1,167,000 -5,542,000 
      illinois eo litigation settlement
    		  30,943,000     0 0          
      georgia eo litigation settlement
    		   0 0 0 -35,000,000 0           
      income taxes payable / receivable
    		-1,332,000 -7,656,000 -556,000 5,724,000 1,089,000 -3,535,000 -1,808,000 19,290,000 -4,299,000 -4,516,000 -9,551,000 -25,050,000 -15,968,000 -5,222,000 13,723,000 378,000 520,000 -4,518,000 
      other liabilities
    		-117,000 -98,000 71,000 -3,485,000 -180,000 48,000 -176,000 -924,000 -297,000 -140,000 -372,000 1,489,000 -468,000 -81,000 -79,000 -195,000 -1,608,000 1,513,000 
      other long-term assets
    		720,000 -473,000 -587,000 -1,756,000 -1,854,000 -1,008,000 -2,224,000 3,933,000 -4,529,000 254,000 104,000 -4,259,000 -4,426,000 -341,000 -4,027,000 -334,000 267,000 -282,000 
      net cash from operating activities
    		71,154,000 57,416,000 55,521,000 55,717,000 97,453,000 61,295,000 9,699,000 113,123,000 41,849,000 -336,575,000 33,871,000 176,035,000 108,256,000 49,967,000 66,351,000 80,938,000 78,097,000 56,159,000 
      capex
    		-29,264,000 -33,964,000 -6,876,000 -72,062,000 -33,555,000 -43,837,000 -19,436,000 -64,489,000 -52,618,000 -49,209,000 -31,939,000 -92,059,000 -53,719,000 -35,546,000 -41,264,000 -16,109,000 -23,847,000 -20,942,000 
      free cash flows
    		41,890,000 23,452,000 48,645,000 -16,345,000 63,898,000 17,458,000 -9,737,000 48,634,000 -10,769,000 -385,784,000 1,932,000 83,976,000 54,537,000 14,421,000 25,087,000 64,829,000 54,250,000 35,217,000 
      investing activities:
    		                  
      purchases of property, plant and equipment
    		-36,172,000 -31,229,000 -19,918,000 -65,870,000 -36,389,000 -41,921,000 -34,890,000 -64,826,000 -52,015,000 -53,134,000 -45,000,000 -110,642,000 -71,642,000 -35,546,000 -41,264,000 -16,109,000 -23,847,000 -20,942,000 
      other investing activities
    		2,837,000 0 37,000 0 37,000 0 37,000 0 37,000 0 32,000 34,000   16,000    
      net cash from investing activities
    		-33,335,000 -31,229,000 -19,881,000 -65,870,000 -36,352,000 -41,921,000 -34,853,000 -64,826,000 -51,978,000 -53,134,000 -44,968,000 -110,158,000 -71,192,000 -35,483,000 -72,263,000 -16,596,000 -24,455,000 -46,519,000 
      financing activities:
    		                  
      proceeds from long-term borrowings
    		    0    0 0 500,000,000        
      payment of long-term borrowings
    		                  
      payments of debt issuance costs and debt discount
    		-1,593,000   -17,000 -1,850,000    -973,000          
      buyout of leased facility
    		   0 0              
      shares withheld for employee taxes on equity awards
    		-207,000 -54,000 -3,600,000                
      other financing activities
    		-539,000 -789,000 -704,000 1,670,000 -804,000 -508,000 -2,664,000 1,546,000 -1,231,000 -495,000 -1,627,000 -1,452,000 -1,056,000 -418,000     
      net cash from financing activities
    		-77,339,000 -6,933,000 -8,087,000 -6,548,000 -2,654,000 -29,421,000 -11,941,000 -3,793,000 -3,454,000 -710,000 273,916,000 -1,483,000 -1,083,000 -449,000 -1,782,000 -103,414,000 -8,307,000 -3,783,000 
      effect of exchange rate changes on cash and cash equivalents
    		6,274,000 8,937,000 -337,000 -12,916,000 2,277,000 -5,015,000 -1,739,000 4,616,000 -4,373,000 729,000 1,067,000 -6,357,000 -2,287,000 487,000 -301,000 -2,233,000 2,873,000 -295,000 
      net increase in cash and cash equivalents, including restricted cash
    		-33,246,000 28,191,000 27,216,000 -29,617,000   -38,834,000 49,120,000 -17,956,000 -389,690,000 263,886,000 58,037,000 33,694,000 14,522,000 -7,995,000 -41,305,000 48,208,000 5,562,000 
      cash and cash equivalents, including restricted cash, at beginning of period
    		0 0 278,865,000 0 0 0 301,654,000 0 0 0 396,294,000 106,924,000 106,924,000 106,924,000 0 0 0 102,454,000 
      cash and cash equivalents, including restricted cash, at end of period
    		-33,246,000 28,191,000 306,081,000 -29,617,000 60,724,000 -15,062,000 262,820,000 49,120,000 -17,956,000 -389,690,000 660,180,000 164,961,000 140,618,000 121,446,000 -7,995,000 -41,305,000 48,208,000 108,016,000 
      supplemental disclosures of cash flow information:
    		                  
      cash paid during the period for interest
    		26,884,000 55,300,000 47,416,000 37,145,000 31,610,000 41,434,000 69,735,000 23,146,000 72,344,000 42,896,000 35,456,000 65,045,000 42,057,000 15,809,000 5,046,000 17,111,000 16,870,000 19,745,000 
      cash paid during the period for income taxes, net of tax refunds received
    		15,400,000 19,992,000 12,215,000 23,382,000 14,733,000 17,877,000 9,837,000 7,623,000 14,997,000 13,576,000 14,014,000 56,474,000 37,340,000 13,505,000 20,085,000 9,137,000 11,224,000 11,561,000 
      purchases of property, plant and equipment included in accounts payable
    		6,908,000 -2,735,000 13,042,000 -6,192,000 2,834,000 -1,916,000 15,454,000 337,000 -603,000 3,925,000 13,061,000 18,583,000 17,923,000      
      illinois eo litigation settlements
    		                  
      payment on long-term borrowings
    		 -3,774,000 -3,773,000   -2,259,350,000 -1,250,000            
      unrealized loss on derivatives not designated as hedging instruments
    		  1,604,000    1,833,000            
      payments of debt issuance costs
    		  -10,000    -1,291,000    -24,457,000  -27,000 -31,000   -226,000 -3,435,000 
      buyout of leased facilities
    		      -6,736,000            
      impairment of investment in unconsolidated affiliate
    		           9,613,000 9,613,000      
      unrealized foreign exchange (gain) loss
    		   -12,582,000   -5,061,000     -5,610,000       
      unrealized gain on derivatives not designated as hedging instruments
    		       -2,724,000   227,000 -4,323,000  -7,364,000     
      purchase of regulatory compliance associates inc., net of cash acquired
    		                  
      proceeds from revolving credit facility and long-term borrowings
    		                  
      payment of revolving credit facility
    		       0 0          
      payments of long-term borrowings
    		                  
      unrealized foreign exchange (gains) losses
    		                  
      net decrease in cash and cash equivalents, including restricted cash
    		                  
      payment on revolving credit facility
    		          -200,000,000        
      loss on extinguishment of debt
    		              4,000 6,365,000 0 14,312,000 
      purchase of bioscience laboratories, llc, net of cash acquired
    		              0 230,000 -608,000 -13,152,000 
      purchase of mandatorily redeemable noncontrolling interest in nelson laboratories fairfield, inc.
    		              0 0 0 -12,425,000 
      purchase of noncontrolling interests in china subsidiaries
    		              0 -698,000   
      payments of debt issuance costs and prepayment premium
    		           -31,000   -74,000    
      balance at january 1, 2021
    		                  
      acquisition of noncontrolling interests
    		                  
      issuance of shares
    		                  
      share-based compensation plans
    		           -789,000 -28,000      
      comprehensive income
    		                  
      pension and post-retirement plan adjustments, net of tax
    		                  
      foreign currency translation
    		                  
      interest rate derivatives, net of tax
    		                  
      balance at december 31, 2021
    		                  
      balance at december 31, 2022
    		                  
      balance at december 31, 2023
    		                  
      adjustment to purchase of regulatory compliance associates inc.
    		           450,000 450,000 63,000     
      unrealized foreign exchange losses
    		            1,274,000 2,430,000     
      unrealized gains on derivatives not designated as hedging instruments
    		            -8,029,000      
      unrealized foreign exchange loss
    		          802,000        
      purchase of iotron industries canada, inc., net of cash acquired
    		                  
      proceeds from issuance of common stock, net of underwriting discounts and issuance costs
    		                  
      repurchase of common shares
    		                  
      payments on revolving credit facility and long-term borrowings
    		                  
      balance at january 1, 2020
    		                  
      repurchase of shares
    		                  
      balance at december 31, 2020
    		                  
      payments on debt
    		                  
      balance at june 30, 2022
    		           282,902,000 282,902,000      
      balance at september 30, 2022
    		           282,113,000       
      balance at march 31, 2022
    		            282,930,000      
      equipment purchases included in accounts payable
    		             9,508,000 -3,000 4,857,000 2,281,000 7,389,000 
      impairment of long-lived assets
    		                  
      share-based non-cash compensation expense
    		                  
      unrealized foreign exchange (gains) / losses
    		                 2,354,000 
      unrealized gain on embedded derivative instruments
    		                  
      dividends and distributions to shareholders
    		                  
      balance at january 1, 2019
    		                  
      cumulative-effect adjustment upon adoption of asu 2014-09
    		                  
      interest rate swaps
    		                  
      balance at december 31, 2019
    		                  
      unrealized foreign exchange losses /
    		               -382,000   
      unrealized (gain) / loss on embedded derivative instruments
    		               1,190,000 -761,000 -853,000 
      proceeds from borrowings
    		                  
      proceeds from revolving credit facility
    		                  
      payments on long-term borrowings
    		                  
      gain on interest rate swap
    		                  
      net cash from (provided by) financing activities
    		                  
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.